Clinical experiences with beta adrenergic blocking therapy on burned patients.
The cachexy which appears in the toxicoseptic phase of burn injuries can be prevented by the regular use of beta-adrenergic blocking drugs. This therapy is based upon data which maintain that the burned organism passes through a beta-modulated adrenergic receptor state as a result of the endocrine changes taking place between the 3rd and the 5th post-burn day. The author describes his own positive experiences of beta-adrenergic blocking therapy. The possible contra-indications (obstructive lung diseases, shock) to this therapy are discussed. Finally he draws attention to some of the side effects which were observed (E.C.G. conduction disturbances).
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D001835:Body Weight; D002056:Burns / Q000188:drug therapy*; D002100:Cachexia / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D008168:Lung / Q000000981:diagnostic imaging; D008297:Male; D010313:Partial Pressure; D011859:Radiography; D013997:Time Factors
D000319:Adrenergic beta-Antagonists